ALC Latest Press Releases

-- October 20, 2026 --

Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2 Business Wire 4:35 PM

-- October 16, 2026 --

FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes Business Wire 3:57 PM

-- September 28, 2026 --

Introducing Systane PRO PRESERVATIVE-FREE: Alcon's Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief Business Wire 10:15 AM

-- September 3, 2026 --

Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control Business Wire 9:00 AM

-- August 26, 2026 --

Alcon Prices EUR 500 Million Senior Notes Offering Business Wire 5:00 PM

-- August 10, 2026 --

New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth Business Wire 4:30 PM

-- July 6, 2026 --

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs Globe Newswire 4:15 PM

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs Business Wire 4:15 PM

Market Data Delayed 15 Minutes